Influence
July 14, 2025

Risk for metachronous advanced neoplasia in patients with a modified definition of advanced adenoma: data from the New Hampshire colonoscopy registry

Thomas Imperiale

Published in the Clinical Gastroenterology and Hepatology. Here is a link to the article.

Regenstrief Institute authors: Thomas Imperiale, M.D.

A new analysis using data from the New Hampshire Colonoscopy Registry examined the risk of metachronous advanced neoplasia (AN) and colorectal cancer (CRC) in individuals with different subtypes of advanced adenomas (AA). The study focused on comparing patients with 10–19 mm tubular adenomas (TA) to those with modified AA characteristics—high-grade dysplasia (HGD), villous histology, or TA >20 mm.

Among 35,941 adults who underwent follow-up colonoscopy ≥12 months after index screening, five groups were analyzed. Groups 4 (TAs 10–19 mm) and 5 (modified AA) demonstrated higher adjusted risk for metachronous AN compared to low-risk Groups 1–3 (Rate Ratios: 3.67 and 4.69, respectively), with overlapping confidence intervals.

However, when the outcome was restricted to modified AA, Group 5 had a significantly higher risk than Group 4 (RR=1.52; 95% CI, 1.04–2.22). Hazard ratios for CRC were also higher in Groups 4 and 5 (HR=2.44 and 3.52, respectively) compared to the low-risk reference groups, though their confidence intervals overlapped.

These findings indicate that while both larger TAs and modified AA subtypes are associated with increased AN and CRC risk, individuals with HGD, villous features, or larger adenomas may warrant particular attention. The results suggest a need for more precise risk stratification in surveillance guidelines. Further studies are recommended to refine subgroup risks within the 10–19 mm TA population.

Authors: 

Joseph C Anderson1, Todd A Mackenzie2, Lynn F Butterly3, Thomas F Imperiale4

Affiliations: 

1Geisel School of Medicine at Dartmouth, Hanover, NH; White River Junction VAMC, White River Junction VT; NH Colonoscopy Registry, Lebanon, NH. Electronic address: Joseph.Anderson@Dartmouth.edu.

2Geisel School of Medicine at Dartmouth, Hanover, NH.

3Geisel School of Medicine at Dartmouth, Hanover, NH; Department of Gastroenterology and Hepatology, DHMC, Lebanon, NH; NH Colonoscopy Registry, Lebanon, NH.

4Indiana University School of Medicine, Dept of Med., Div. of Gastro/Hep, Indianapolis, IN; Richard L. Roudebush VA Medical Center; Regenstrief Institute, Inc.

Partners

Related News

Medications for Alcohol Use Disorder reduce healthcare spending

Medications for Alcohol Use Disorder reduce healthcare spending

Alcohol Use Disorder (AUD) remains a major public health challenge in the United States, contributing to more than 170,000

Low Cancer Screening Rates Among Emergency Department Patients: A Multicenter Retrospective Study.

Published in the journal Cancer investment. Here is a link to the article.  Regenstrief Institute author: Paul I. Musey, M.D., M.S.  The content below

Susan Hickman and Kathleen Unroe lead expansion of advance care planning program

Leadership stability, peer support essential when implementing care programs in nursing homes

Despite a pressing need to improve outcomes and address inequities in nursing homes, there is limited evidence about the

Reimagining real-world health data as essential public infrastructure

Reimagining real-world health data as essential public infrastructure

Researchers propose standards and community oversight to improve interoperability, accountability and public trust The U.S. healthcare system runs on